CDC Clarifies Steps for clinicians to Order Medications to Treat Monkeypox

Published: 07/19/2022

  • Centers for Disease Control and Prevention
Relevant To:
  • Urgent Care,
  • Medical Office,
  • Critical Access Hospitals,
  • Home Health,
  • Hospitals,
  • Ambulatory Care,
  • Clinical Lab,
  • Rural Health Clinics

The Centers for Disease Control and Prevention (CDC) is working to make it easier for U.S. healthcare providers to request TPOXX (also called tecovirimat), an antiviral drug that can be used under special circumstances to treat patients with monkeypox.

CDC recently posted information clarifying the current TPOXX ordering process: Obtaining and Using TPOXX (Tecovirimat).

The web posting clarifies that forms and other documentation required for obtaining TPOXX can be submitted after clinicia

Sign Up for Free Trial